Germany DAX40 - a Watershed Moment

Period Return
2.5%
Return Rank
Subpar
Risk Exposure
Below Average

Exporting €1.56 trillion in 2023, 47% of its GDP, the Germany economy has benefitted greatly from European integration and from the tailwinds of globalization over the last 20 years

The exchange rate adopted on introduction of the euro in 1999 has been an implicit devaluation of the Deutsche Mark, propelling German exports in Europe, which has remained its main market (stable at 54.2% of exports  to EU-28 in 2023), and around the world

On foreign export markets, in 2023, the U.S. came first (10.9%), followed by France (8%), the Netherlands (7.6%) and China (notably down at 6.7% from 9% in 2021)

The strong presence of German exports to Poland (6.1%) stands out, followed by Eastern Europe countries the Czech Republic, Hungary, Romania and Slovakia

 

Globalization is being thrown into reverse, China’s economy signals weakness, the U.S. markets anticipate stagflation and the war in Ukraine compounds uncertainties in Europe

On the supply side, the cost of energy, the boost to defense spending, and ambitious investments to substitute for Russian gas (LNG stations and expanding renewables) all point to a potential loss of industrial competitiveness

A marked increase in foreign trade balance in the first half 2024 (+28.7% vs 2023) signals a severely weakening economy  with imports dropping by 6.2% (vs exports decreasing by only 1.6%)

 

Zeitenwende” according to Chancellor Scholz – a turning point indeed…

The 40 constituents of the DAX® Index will mirror how the German economy rides out the storm

The iShares MSCI Eurozone ETF is the benchmark of the selection

DAX-40 member Hannover Rück is not listed because of faulty OTC data affecting volatility computation

Theme Components
Name
Ticker
Sector
Industry
Cur. Price
Mkt. Cap
Performance
Momentum
Risk Rank
Risk Contrib
 
QIAGEN QGEN Health CareMedical Laboratories & Research37.568.1 B-13.2% Weak Up Below Average
Sartorius AG SARTF Health CareMedical Laboratories & Research212.80-9.8% Neutral Low Risk
Fresenius Medical Care (ADR) FMS Health CareKidney Failure21.9312 B-17.6% Neutral Below Average
Merck KGaA (ADR) MKKGY Health CareDrug Manufacturers - Diversified33.75-29.4% Strong Up Below Average
Bayer (ADR) BAYRY Health CareDrug Manufacturers - Diversified15.19-98.0% Weak Up Above Average
Siemens Healthineers (ADR) SMMNY Health CareMedical Devices19.96--27.4% Neutral Low Risk
Deutsche Bank (ADR) DB FinanceGlobal Banks32.2063 B16.1% Weak Up Below Average
Deutsche Boerse (ADR) DBOEY FinanceExchange28.20--11.6% Weak Down Low Risk
Allianz (ADR) ALIZY FinanceGlobal Insurance - Multi-line47.88-18.8% Weak Up Low Risk
Commerzbank (ADR) CRZBY FinanceCommercial Banks (National & Regional)43.39-31.1% Neutral Average Risk
1 – 10 of 39